Home > Income Statement > MOREPEN LABORATORIES

MOREPEN LABORATORIES
Revenue

    Back to Income Statement
MOREPEN LABORATORIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MOREPEN LABORATORIES
Please provide your vote to see the results

MOREPEN LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹1,812 Cr₹1,690 Cr₹1,418 Cr₹1,547 Cr₹1,188 Cr

What is the latest Revenue of MOREPEN LABORATORIES ?

The latest Revenue ratio of MOREPEN LABORATORIES is ₹1,812 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹1,812 Cr
Mar2025₹1,690 Cr
Mar2024₹1,418 Cr
Mar2023₹1,547 Cr
Mar2022₹1,188 Cr

How is Revenue of MOREPEN LABORATORIES Trending?

Years Revenue % Change
Mar2026 ₹1,812 Cr
7.17
Mar2025 ₹1,690 Cr
19.25
Mar2024 ₹1,418 Cr
-8.36
Mar2023 ₹1,547 Cr
30.20
Mar2022 ₹1,188 Cr -

Compare Revenue of peers of MOREPEN LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MOREPEN LABORATORIES ₹7,261.0 Cr 14.4% 13.6% 161.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr 0.9% -5% 3.2% Stock Analytics
DIVIS LABORATORIES ₹251,611.0 Cr 3.6% -1.4% 37.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹175,182.0 Cr 1.7% -6.7% 28% Stock Analytics
CIPLA ₹109,063.0 Cr 2.8% -3.9% -17.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,926.0 Cr 5.4% 8.7% 1.6% Stock Analytics


MOREPEN LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MOREPEN LABORATORIES

14.4%

13.6%

161.3%

SENSEX

-0.3%

-1.6%

-12.3%


You may also like the below Video Courses